Advertisement

Topics

Dana-Farber Cancer Institute Release: PCF-Funded ICECaP Study Identifies Earlier Clinical Trial Endpoint That Can Be Used To Indicate Effectiveness Of New Treatments

20:00 EDT 10 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Dana-Farber Cancer Institute Release: PCF-Funded ICECaP Study Identifies Earlier Clinical Trial Endpoint That Can Be Used To Indicate Effectiveness Of New Treatments

NEXT ARTICLE

More From BioPortfolio on "Dana-Farber Cancer Institute Release: PCF-Funded ICECaP Study Identifies Earlier Clinical Trial Endpoint That Can Be Used To Indicate Effectiveness Of New Treatments"

Quick Search
Advertisement